David F Hale - Net Worth and Insider Trading
David F Hale Net Worth
The estimated net worth of David F Hale is at least $330,926 dollars as of 2024-04-26. David F Hale is the Director of Oncternal Therapeutics Inc and owns about 31,304 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $250,432. David F Hale is the Director of Conatus Pharmaceuticals Inc and owns about 143,739 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $80,494. David F Hale is also the Director of Biocept Inc and owns about 4,011 shares of Biocept Inc (BIOCQ) stock worth over $0. Details can be seen in David F Hale's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David F Hale has not made any transactions after 2024-02-23 and currently still holds the listed stock(s).
Transaction Summary of David F Hale
David F Hale Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David F Hale owns 5 companies in total, including Biocept Inc (BIOCQ) , Oncternal Therapeutics Inc (ONCT) , and Histogen Inc (HSTO) among others .
Click here to see the complete history of David F Hale’s form 4 insider trades.
Insider Ownership Summary of David F Hale
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BIOCQ | Biocept Inc | 2021-12-09 | director & EXECUTIVE CHAIRMAN |
| ONCT | Oncternal Therapeutics Inc | 2024-02-23 | director |
| HSTO | Histogen Inc | 2013-07-24 | director |
| LGNZZ | Metabasis Therapeutics Inc | 2009-06-23 | director |
| DRMA | Dermata Therapeutics Inc | 2021-08-12 | director |
David F Hale Latest Holdings Summary
David F Hale currently owns a total of 3 stocks. Among these stocks, David F Hale owns 31,304 shares of Oncternal Therapeutics Inc (ONCT) as of February 23, 2024, with a value of $250,432 and a weighting of 75.68%. David F Hale owns 143,739 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $80,494 and a weighting of 24.32%. David F Hale also owns 4,011 shares of Biocept Inc (BIOCQ) as of December 9, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of David F Hale
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2024-02-23 | 31,304 | 8.00 | 250,432 |
| CNAT | Conatus Pharmaceuticals Inc | 2013-07-30 | 143,739 | 0.56 | 80,494 |
| BIOCQ | Biocept Inc | 2021-12-09 | 4,011 | 0.00 | 0 |
Holding Weightings of David F Hale
David F Hale Form 4 Trading Tracker
According to the SEC Form 4 filings, David F Hale has made a total of 1 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 980 shares on February 23, 2024, which cost David F Hale around $8,859.
According to the SEC Form 4 filings, David F Hale has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the acquisition of 2,588 shares on July 30, 2013, which cost David F Hale around $28,468.
According to the SEC Form 4 filings, David F Hale has made a total of 2 transactions in Biocept Inc (BIOCQ) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Biocept Inc is the sale of 445 shares on December 9, 2021, which brought David F Hale around $1,807.
Insider Trading History of David F Hale
- 1
David F Hale Trading Performance
GuruFocus tracks the stock performance after each of David F Hale's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David F Hale is 14.48%. GuruFocus also compares David F Hale's trading performance to market benchmark return within the same time period. The performance of stocks bought by David F Hale within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David F Hale's insider trading performs compared to the benchmark.
Performance of David F Hale
Average Return
-9.65%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.91 | 14.48 | 9.25 | -9.65 | -56.92 | -61.56 |
| Relative Return to S&P 500(%) | -13.86 | 9.25 | 3.54 | -27.26 | -70.05 | -72.68 |
David F Hale Ownership Network
Ownership Network List of David F Hale
Ownership Network Relation of David F Hale
David F Hale Owned Company Details
What does Biocept Inc do?
Who are the key executives at Biocept Inc?
David F Hale is the director & EXECUTIVE CHAIRMAN of Biocept Inc. Other key executives at Biocept Inc include VP & Controller Robert Walsh , Chief Operations Officer Philippe Marchand , and Sr. V.P. & General Counsel Darrell Taylor .
Biocept Inc (BIOCQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biocept Inc (BIOCQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biocept Inc (BIOCQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biocept Inc (BIOCQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biocept Inc Insider Transactions
David F Hale Mailing Address
Above is the net worth, insider trading, and ownership report for David F Hale. You might contact David F Hale via mailing address: 1042-b North El Camino Real, Suite 430, Encinitas Ca 92024.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
